The clinical and immunological characteristics that were statistically associated with positive EULAR/ACR-2019 criteria were renal involvement, arthritis, low C3 and C4 and a positive test for DNA, with all of those important and highly specific to SLE [21]. The gene discussed is C3; the disease is systemic lupus erythematosus.